Craig Boerner

VUMC’s ECMO program has expanded to areas outside of the Cardiovascular Intensive Care Unit.

Study shows young, healthy adults died from COVID-19 due to ECMO shortage

Vanderbilt research found that nearly 90 percent of COVID-19 patients who qualified for, but did not receive, ECMO due to a shortage of resources during the height of the pandemic died in the hospital, despite being young with few other health issues

Study shows lifesaving benefit of baricitinib for ventilated COVID patients

Vanderbilt research shows that critically ill COVID-19 patients on a mechanical ventilator or extracorporeal membrane oxygenation lived more often when randomized to receive baricitinib.

Study finds shorter treatment better for young children with outpatient pneumonia

A Vanderbilt study found that five days of antibiotics is superior to 10 days for children with community-acquired pneumonia who are not hospitalized.

Potential Rett syndrome drug shows promising results in phase 3 trial

A potential first-of-its-kind drug to treat the symptoms of Rett syndrome received positive top-line results from a phase 3 trial led by investigators from Vanderbilt University Medical Center to evaluate efficacy and safety.

Case to depart role as Chief Compliance Officer

Vanderbilt University Medical Center Chief Compliance Officer Edward (Ted) Case, JD, is leaving VUMC to return to private law practice.

VUMC, NIH launch clinical trial to test novel therapies to protect host tissue against COVID-19

Vanderbilt University Medical Center researchers, supported by the National Institutes of Health (NIH), are leading a nationwide clinical trial to explore the safety and effectiveness of a group of novel drugs designed to protect patients hospitalized with COVID-19 at high risk of poor outcomes.

1 5 6 7 8 9 19